Concepedia

Olga Bandman

OB

Statistics

Publications

6

Citations

191

H-Index

6

Active since

1989

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Hammersmith Hospital

Royal London Hospital

Barts Health NHS Trust

Olga Bandman is an author at Massachusetts General Hospital specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

1989–2020

6

Publications

6

Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

C. Michael Gibson, Gerald Chi, Rim Halaby et al. · Circulation · 2016 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +17

The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

C. Michael Gibson, Rim Halaby, Serge Korjian et al. · American Heart Journal · 2016 · 55 citations

Medicine, Internal Medicine, Pharmacotherapy +15

A randomized trial of budiodarone in paroxysmal atrial fibrillation

Michael D. Ezekowitz, Rangadham Nagarakanti, Andrzej Lubiński et al. · Journal of Interventional Cardiac Electrophysiology · 2011 · 26 citations

Medicine, Cardiology, Pharmacology +10

Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia

David J. Kuter, Ralph V. Boccia, Eun‐Ju Lee et al. · Blood · 2019 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +11

Oral Rilzabrutinib, a Bruton Tyrosine Kinase Inhibitor, Showed Clinically Active and Durable Platelet Responses and Was Well-Tolerated in Patients with Heavily Pretreated Immune Thrombocytopenia

David J. Kuter, Merlin Efraim, Vickie McDonald et al. · Blood · 2020 · 15 citations

Medicine, Hematology, Pharmacology +15

1–5 of 6